ASSOCIATION OF CIRCULATING ENDOTHELIAL CELLS AND ENDOTHELIAL PROGENITOR CELLS IN DYSLIPIDEMIC CHILDREN AND ADOLESCENTS
Canadian Journal of Cardiology2014Vol. 30(10), pp. S191–S191
Related Papers
- → Rosuvastatin: a new inhibitor of HMG-CoA reductase for the treatment of dyslipidemia(2003)119 cited
- → Benefits of Rosuvastatin in Cardiovascular Protection Remain Unclear After HOPE-3(2016)3 cited
- [Clinical trials with rosuvastatin: efficacy and safety of its use].(2003)
- Rosuvastatin: do we need another statin?(2001)
- Clinical efficacy of rosuvastatin in lipid management in Chinese patients in Hong Kong(2009)